Presentation Effectiveness of Renal Denervation for Resistant Hypertension: Systematic Review and Meta-analysis Presenter: M.I. Davis May 14, 2013
Presentation Vascular Lesions Induced by Renal Nerve Ablation as Assessed by Optical Coherence Tomography Presenter: C. Templin May 01, 2013
Presentation Acetylcysteine for the Prevention of Renal Outcomes in Patients with Diabetes Undergoing Coronary and Peripheral Angiography Presenter: Otavio Berwanger April 18, 2013
Presentation Fellows 2013 Renal Denervation for Resistant Hypertension Presenter: Ajay Kirtane April 17, 2013
Presentation TCT 2013 Trend of clinical outcomes in patients with chronic kidney disease and end-stage renal disease following percutaneous coronary intervention. Presenter: James Lai, M. Chadi Alraies, Wael Aljaroudi, Stephen Ellis, Leslie Cho January 31, 2013
Presentation TCT 2013 Renal Sympathetic Denervation - Inducing An Instantaneous And Persisting 24h Ambulatory Blood Pressure Drop In Patients With Resistant Hypertension – Results From The... Presenter: Alexander Plehn, Sebastian Dietz, Konstantin Heinroth, Henning Lemm, Maria Leuthold, Silke Markau, Uwe Raaz, Therese Schubert, Alexander Vogt, Karl Werdan January 31, 2013
Presentation TCT 2013 Renal Artery Aneurysms. First Human Treatment With The Multilayer Flow Modulator Presenter: Michel Henry, Amira BENJELLOUN, Isabelle Henry, Antonios Polydorou January 31, 2013
Presentation TCT 2013 Renal Angioplasty And Stenting. Limitations. Role Of Embolic Protection Devices Presenter: Isabelle Henry, Amira BENJELLOUN, Michel Henry January 31, 2013
Presentation TCT 2013 Is Urinary Neutrophil Gelatinase-Associated Lipocalin the “Renal Troponin” in Invasive Cardiology? Presenter: Tilman Perrin, Eric Descombes, St?phanie Gobet, Jean-Luc Magnin, Magali Gachet, Ould Hemett, Daniel Hayoz, Val?rie Stolt, G?rard Baeriswyl, Jean-Christophe Stauffer, Jean-Jacques Goy, Mario Togni, St?phane Cook January 31, 2013
Presentation TCT 2013 Histologic analysis of renal nerve injury following catheter-based renal denervation in obese, hypertensive canines Presenter: Jeffrey Henegar, Yongxing Zhang, Rita DeRama, Cary Hata, John Hall January 31, 2013
Presentation TCT 2013 Efficacy of renal denervation is positively impacted by longitudinal treatments Presenter: Meital Mazor January 31, 2013
Presentation TCT 2013 Clinical Efficacy and Cost per Quality-Adjusted –Life Years with Pararenal Endovascular Aortic Repair (PEVAR) for Para-renal AAA compared with Open Surgical Repair. Presenter: Sherif Sultan, Niamh Hynes January 31, 2013
Presentation TCT 2013 A Preclinical Comparative Histological Evaluation of the Renal Artery and Nerves in the Human Cadaver and Swine model Presenter: Radhika Tunstall, Dawn Winsor-Hines, Martin Willard, Barbara Huibregtse January 31, 2013
Presentation TCT 2013 A Pilot Study on Renal Sympathetic Denervation for Resistant Hypertension in the West of Ireland Presenter: IMTIAZ KALYAR, James Gleeson, Sajjad Matiullah, Faisal Sharif January 31, 2013
Presentation Renal Sympathetic Denervation Does Not Aggravate Functional or Structural Renal Damage Presenter: Oliver D?rr January 08, 2013
Presentation Renal Sympathetic Denervation for Treatment of Drug-resistant Hypertension Presenter: Murray Esler December 19, 2012
Presentation ICI 2012 Vessix Renal Denervation System: Achieving Safety and Efficacy in Less Than One Minute Presenter: James R. Margolis December 02, 2012
Presentation Potential Lifetime Cost-effectiveness ofCatheter-Based Renal Sympathetic Denervation in Patients with Resistant Hypertension Presenter: Marc Dorenkamp November 29, 2012
Presentation TCT 2012 Case: A 62-Year-Old Diabetic Patient with ACS and Moderate Renal Failure Presenter: Verghese Mathew October 26, 2012
Presentation TCT 2012 Initiating a Renal Denervation Program Presenter: George Dangas October 25, 2012